News und Analysen
EQS-News: Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved
EQS-News: Carl Zeiss Meditec closes fiscal year 2023/24 with slight decline in revenue- Adjusted EBIT forecast achieved
EQS-News: Reorganization of the Eckert & Ziegler Executive Board
EQS-News: Reorganization of the Eckert & Ziegler Executive Board
EQS-News: Eckert & Ziegler and SK Biopharmaceuticals Sign Actinium-225 Supply Agreement
EQS-News: Eckert & Ziegler and SK Biopharmaceuticals Sign Actinium-225 Supply Agreement
EQS-News: Eckert & Ziegler Achieves Further Earnings Growth and Double-Digit Sales Growth in the Medical Segment
EQS-News: Eckert & Ziegler Achieves Further Earnings Growth and Double-Digit Sales Growth in the Medical Segment
EQS-News: Eckert & Ziegler Gains Approval for GalliaPharm® in Japan
EQS-News: Eckert & Ziegler Gains Approval for GalliaPharm® in Japan
EQS-News: Eckert & Ziegler: Berenberg Starts Coverage with a “Buy” Recommendation and a Price Target of € 24 – Price Potential 47%
EQS-News: Eckert & Ziegler: Berenberg Starts Coverage with a “Buy” Recommendation and a Price Target of € 24 – Price Potential 47%
EQS-News: Eckert & Ziegler: Further Increase in Earnings in the First Half of 2025
EQS-News: Eckert & Ziegler: Further Increase in Earnings in the First Half of 2025
EQS-News: Eckert & Ziegler: Implementation of the Share Split by Issuing Bonus Shares to Be Effective on 15 August 2025
EQS-News: Eckert & Ziegler: Implementation of the Share Split by Issuing Bonus Shares to Be Effective on 15 August 2025
EQS-News: Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101
EQS-News: Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101
EQS-News: Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation.
EQS-News: Eckert & Ziegler: Capital Increase Entered in the Commercial Register. Share Split in Preparation.
EQS-News: Eckert & Ziegler: Outstanding Training Quality Once Again Awarded
EQS-News: Eckert & Ziegler: Outstanding Training Quality Once Again Awarded
EQS-News: Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50
EQS-News: Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50
EQS-News: Eckert & Ziegler: Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany
EQS-News: Eckert & Ziegler: Illuccix® PSMA-PET Imaging Agent Receives Approval in Germany
EQS-News: Eckert & Ziegler Organizes Third Boston Radionuclide Theranostics Forum
EQS-News: Eckert & Ziegler Organizes Third Boston Radionuclide Theranostics Forum
EQS-News: Eckert & Ziegler Wins “Best Managed Companies Award” for the Second Time
EQS-News: Eckert & Ziegler Wins “Best Managed Companies Award” for the Second Time
EQS-News: Eckert & Ziegler Starts with Earnings Growth in Q1 2025 and Confirms Full-Year Forecast
EQS-News: Eckert & Ziegler Starts with Earnings Growth in Q1 2025 and Confirms Full-Year Forecast
EQS-News: Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm
EQS-News: Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Pentixapharm
EQS-News: Eckert & Ziegler Proposes Dividend of € 0.50 for FY 2024
EQS-News: Eckert & Ziegler Proposes Dividend of € 0.50 for FY 2024
EQS-News: Eckert & Ziegler: US Consul Visits Radiopharmaceutical Production in Braunschweig
EQS-News: Eckert & Ziegler: US Consul Visits Radiopharmaceutical Production in Braunschweig
EQS-News: Eckert & Ziegler: Record year 2024 with new all-time highs
EQS-News: Eckert & Ziegler: Record year 2024 with new all-time highs
EQS-News: Eckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-225 for Comprehensive Development Activities
EQS-News: Eckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-225 for Comprehensive Development Activities
EQS-News: Eckert & Ziegler and AtomVie Global Radiopharma Sign a Global Agreement for Lutetium-177 Supply
EQS-News: Eckert & Ziegler and AtomVie Global Radiopharma Sign a Global Agreement for Lutetium-177 Supply
EQS-News: Eckert & Ziegler Enters Strategic Partnership with Bicycle Therapeutics for Radioisotope Supply and Contract Development and Manufacturing of Bicycle Radio Conjugates
EQS-News: Eckert & Ziegler Enters Strategic Partnership with Bicycle Therapeutics for Radioisotope Supply and Contract Development and Manufacturing of Bicycle Radio Conjugates
EQS-News: Eckert & Ziegler Ensures Business Continuity After Cyber-Attack
EQS-News: Eckert & Ziegler Ensures Business Continuity After Cyber-Attack
EQS-Adhoc: Eckert & Ziegler Affected by Cyber Attack
EQS-Adhoc: Eckert & Ziegler Affected by Cyber Attack